Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Zhu S.,,Expression and clinical implications of HAb18G/CD147 in hepatocellular carcinoma,2015,Hepatology Research,20,10.1111/hepr.12320,China,Article,Xi'an,0,Journal,2-s2.0-84921057207
Siegel R.,,"Cancer statistics, 2015",2015,CA Cancer Journal for Clinicians,10190,10.3322/caac.21254,United States,Article,Atlanta,1,Journal,2-s2.0-84920837701
Xiong L.,,The biological function and clinical utilization of CD147 in human diseases: A review of the current scientific literature,2014,International Journal of Molecular Sciences,81,10.3390/ijms151017411,China,Review,Beijing,1,Journal,2-s2.0-84907855682
Bian H.,,Randomized trial of [<sup>131</sup>I] metuximab in treatment of hepatocellular carcinoma after percutaneous radiofrequency ablation,2014,Journal of the National Cancer Institute,31,10.1093/jnci/dju239,China,Article,Xi'an,1,Journal,2-s2.0-84929461835
Kong L.M.,,"A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis",2014,Cancer Research,103,10.1158/0008-5472.CAN-13-3555,China,Article,Xi'an,1,Journal,2-s2.0-84904269441
Ye N.,,Small molecule inhibitors targeting activator protein 1 (AP-1),2014,Journal of Medicinal Chemistry,76,10.1021/jm5004733,United States,Review,Galveston,1,Journal,2-s2.0-84906856323
Xu X.,,Expression of HAb18G/CD147 and its localization correlate with the progression and poor prognosis of non-small cell lung cancer,2013,Pathology Research and Practice,22,10.1016/j.prp.2013.02.015,China,Article,Guangzhou,0,Journal,2-s2.0-84878399155
Yang C.,,C-Jun-mediated anticancer mechanisms of tylophorine,2013,Carcinogenesis,33,10.1093/carcin/bgt039,Taiwan;Taiwan,Article,Hsinchu;Zhunan,1,Journal,2-s2.0-84878970288
Zhao S.,,High expression of CD147 and MMP-9 is correlated with poor prognosis of triple-negative breast cancer (TNBC) patients,2013,Medical Oncology,54,10.1007/s12032-012-0335-4,China,Article,Harbin,0,Journal,2-s2.0-84880636957
Bhagirath D.,,"Expression of CD147, BIGH3 and Stathmin and their potential role as diagnostic marker in patients with urothelial carcinoma of the bladder",2012,Clinica Chimica Acta,38,10.1016/j.cca.2012.05.005,India,Article,New Delhi,0,Journal,2-s2.0-84864393097
Zhong W.,,Extracellular matrix metalloproteinase inducer expression has an impact on survival in human bladder cancer,2010,Cancer Epidemiology,12,10.1016/j.canep.2010.04.007,China,Article,Guangzhou,0,Journal,2-s2.0-77955087592
Han Z.,,Expression and Clinical Significance of CD147 in Genitourinary Carcinomas<sup>1</sup>,2010,Journal of Surgical Research,32,10.1016/j.jss.2008.11.838,China,Article,Guangzhou,0,Journal,2-s2.0-77950917026
Weiwei Y.,,Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication,2009,Pathology Research and Practice,39,10.1016/j.prp.2009.05.010,China,Article,Nanchang,0,Journal,2-s2.0-70249106026
Sharma S.,,Diagnosis and treatment of bladder cancer,2009,American Family Physician,40,,United States;United States,Review,Omaha;Omaha,0,Journal,2-s2.0-70349643764
Liang Y.,,CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value,2009,Cancer Investigation,54,10.1080/07357900802709167,China,Article,Guangzhou,0,Journal,2-s2.0-68849132734
Van Tilborg A.,,Bladder cancer biomarkers and their role in surveillance and screening,2009,International Journal of Urology,51,10.1111/j.1442-2042.2008.02174.x,Netherlands,Review,Rotterdam,1,Journal,2-s2.0-58149184034
Mahner S.,,C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma,2008,British Journal of Cancer,83,10.1038/sj.bjc.6604650,Germany,Article,Hamburg,1,Journal,2-s2.0-53849101060
Ramos-Nino M.,,A novel combination: Ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells,2008,Molecular Cancer Therapeutics,13,10.1158/1535-7163.MCT-08-0308,United States,Article,Burlington,1,Journal,2-s2.0-51049098981
Zhong W.,,"CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer",2008,Oncology,80,10.1159/000163852,China,Article,Guangzhou,0,Journal,2-s2.0-53549083786
Xu J.,,HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma,2007,Molecular Cancer Research,136,10.1158/1541-7786.MCR-06-0286,China,Article,Xi'an,1,Journal,2-s2.0-34250854097
Zheng H.C.,,Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: A good marker for local invasion and prognosis,2006,British Journal of Cancer,116,10.1038/sj.bjc.6603425,Japan,Article,Toyama,1,Journal,2-s2.0-33751026616
Riethdorf S.,,High incidence of EMMPRIN expression in human tumors,2006,International Journal of Cancer,178,10.1002/ijc.22062,Germany,Article,Hamburg,1,Journal,2-s2.0-33748485131
Vleugel M.,,c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer,2006,Human Pathology,102,10.1016/j.humpath.2006.01.022,Netherlands,Article,Utrecht,0,Journal,2-s2.0-33745441050
Bossis G.,,Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation,2005,Molecular and Cellular Biology,144,10.1128/MCB.25.16.6964-6979.2005,France,Article,Paris,1,Journal,2-s2.0-23344445127
Hagemann T.,,Macrophages induce invasiveness of epithelial cancer cells via NF-κB and JNK,2005,Journal of Immunology,329,10.4049/jimmunol.175.2.1197,United Kingdom,Article,London,1,Journal,2-s2.0-23244451640
Hess J.,,AP-1 subunits: Quarrel and harmony among siblings,2004,Journal of Cell Science,816,10.1242/jcs.01589,Germany,Article,Heidelberg,1,Journal,2-s2.0-12344252237
Ishibashi Y.,,CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamos cell carcinoma,2004,Cancer,86,10.1002/cncr.20593,Japan,Article,Tokyo,0,Journal,2-s2.0-7044255002
Moreira J.,,Expression of the tumor suppressor protein 14-3-3σ is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-to-mesenchymal transition,2004,Molecular and Cellular Proteomics,72,10.1074/mcp.M300134-MCP200,Denmark,Article,Copenhagen,1,Journal,2-s2.0-2542598849
Eferl R.,,Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53,2003,Cell,362,10.1016/S0092-8674(03)00042-4,Austria,Article,Vienna,1,Journal,2-s2.0-0037462454
Gromova I.,,bc10: A novel human bladder cancer-associated protein with a conserved genomic structure downregulated in invasive cancer,2002,International Journal of Cancer,40,10.1002/ijc.10244,Denmark,Article,Copenhagen,1,Journal,2-s2.0-0036533525
Briggs J.,,"Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells",2002,Oncogene,89,10.1038/sj.onc.1205857,United States,Article,Norfolk,1,Journal,2-s2.0-0037057334
Bamberger A.,,Expression pattern of the AP-1 family in endometrial cancer: Correlations with cell cycle regulators,2001,Journal of Cancer Research and Clinical Oncology,57,10.1007/s004320100255,Germany,Article,Hamburg,0,Journal,2-s2.0-0034885470
Smith L.,,"cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype",1999,Oncogene,178,10.1038/sj.onc.1202989,United States;United States,Article,Bethesda;Fort Collins,1,Journal,2-s2.0-0033613398
Gamberi G.,,C-myc and c-fos in human osteosarcoma: Prognostic value of mRNA and protein expression,1998,Oncology,134,10.1159/000011912,Italy,Article,Bologna,0,Journal,2-s2.0-0031783711
Szabo E.,,Altered cJun expression: An early event in human lung carcinogenesis,1996,Cancer Research,97,,United States,Article,Bethesda,0,Journal,2-s2.0-0030063176
Pagano F.,,"Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification",1991,Journal of Urology,335,10.1016/S0022-5347(17)38244-7,,Article,,0,Journal,2-s2.0-0026098429
Giuliani L.,,Results of radical cystectomy for primary bladder cancer. Retrospective Study of More than 200 Cases,1985,Urology,33,10.1016/0090-4295(85)90119-0,Italy,Article,Genoa,0,Journal,2-s2.0-0022216947
